These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 35462038)
1. Reduction in the infection fatality rate of Omicron variant compared with previous variants in South Africa. Liu Y; Yu Y; Zhao Y; He D Int J Infect Dis; 2022 Jul; 120():146-149. PubMed ID: 35462038 [TBL] [Abstract][Full Text] [Related]
2. A simple model to estimate the transmissibility of the Beta, Delta, and Omicron variants of SARS-COV-2 in South Africa. Yu Y; Yu Y; Zhao S; He D Math Biosci Eng; 2022 Jul; 19(10):10361-10373. PubMed ID: 36031998 [TBL] [Abstract][Full Text] [Related]
3. Omicron SARS-CoV-2 variant of concern: A review on its transmissibility, immune evasion, reinfection, and severity. Mohsin M; Mahmud S Medicine (Baltimore); 2022 May; 101(19):e29165. PubMed ID: 35583528 [TBL] [Abstract][Full Text] [Related]
4. Infectivity versus fatality of SARS-CoV-2 mutations and influenza. Xue L; Jing S; Zhang K; Milne R; Wang H Int J Infect Dis; 2022 Aug; 121():195-202. PubMed ID: 35584743 [TBL] [Abstract][Full Text] [Related]
5. A tentative assessment of the changes in transmissibility and fatality risk associated with Beta SARS-CoV-2 variants in South Africa: an ecological study. Zhao S; Peng Z; Wang MH Pathog Glob Health; 2022 May; 116(3):137-139. PubMed ID: 34928191 [TBL] [Abstract][Full Text] [Related]
6. The immune evasion ability of Delta variant is comparable to that of Beta variant in South Africa. He D; Chen B; Zhao S; Stone L BMC Public Health; 2023 Mar; 23(1):511. PubMed ID: 36927400 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron). Yang W; Shaman JL Elife; 2022 Aug; 11():. PubMed ID: 35943138 [TBL] [Abstract][Full Text] [Related]
8. Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant? Duong BV; Larpruenrudee P; Fang T; Hossain SI; Saha SC; Gu Y; Islam MS Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457468 [TBL] [Abstract][Full Text] [Related]
9. The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0-3.3 Days Can Be Explained by Immune Evasion. Grabowski F; Kochańczyk M; Lipniacki T Viruses; 2022 Jan; 14(2):. PubMed ID: 35215887 [TBL] [Abstract][Full Text] [Related]
10. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review. Kannan S; Shaik Syed Ali P; Sheeza A Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8019-8022. PubMed ID: 34982466 [TBL] [Abstract][Full Text] [Related]
11. Methods for early characterisation of the severity and dynamics of SARS-CoV-2 variants: a population-based time series analysis in South Africa. Reichert E; Schaeffer B; Gantt S; Rumpler E; Govender N; Welch R; Shonhiwa AM; Iwu CD; Lamola TM; Moema-Matiea I; Muganhiri D; Hanage W; Santillana M; Jassat W; Cohen C; Swerdlow D Lancet Microbe; 2022 Oct; 3(10):e753-e761. PubMed ID: 36057266 [TBL] [Abstract][Full Text] [Related]
12. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa. Wang L; Cheng G J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Fan Y; Li X; Zhang L; Wan S; Zhang L; Zhou F Signal Transduct Target Ther; 2022 Apr; 7(1):141. PubMed ID: 35484110 [TBL] [Abstract][Full Text] [Related]
14. Severity of the Omicron SARS-CoV-2 variant compared with the previous lineages: A systematic review. Arabi M; Al-Najjar Y; Mhaimeed N; Salameh MA; Paul P; AlAnni J; Abdelati AA; Laswi I; Khanjar B; Al-Ali D; Elshafeey A; Mhaimeed O; Burney Z; D'Souza A; Sinha P; Bhatti M; Pillai KV; Homssi M; Bshesh K; Yagan L; Zakaria D J Cell Mol Med; 2023 Jun; 27(11):1443-1464. PubMed ID: 37203288 [TBL] [Abstract][Full Text] [Related]
15. COVID-19 outbreak trends in South Africa: A comparison of Omicron (B.1.1.529), Delta (B.1.617.2), and Beta (B.1.351) variants outbreak periods. Al Hasan SM; Saulam J; Mikami F; Kanda K; Yokoi H; Hirao T J Infect Public Health; 2022 Jul; 15(7):726-733. PubMed ID: 35687982 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021. CDC COVID-19 Response Team MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective. Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235 [TBL] [Abstract][Full Text] [Related]
18. [Progress in research of 2019-nCoV Omicron variant]. Huang Y; Li YH; Xie SL; Rong ZH; Li BS; Kang M; Deng AP; Li Y Zhonghua Liu Xing Bing Xue Za Zhi; 2022 May; 43(5):655-662. PubMed ID: 35589568 [TBL] [Abstract][Full Text] [Related]
19. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study. Cloete J; Kruger A; Masha M; du Plessis NM; Mawela D; Tshukudu M; Manyane T; Komane L; Venter M; Jassat W; Goga A; Feucht U Lancet Child Adolesc Health; 2022 May; 6(5):294-302. PubMed ID: 35189083 [TBL] [Abstract][Full Text] [Related]
20. Twice evasions of Omicron variants explain the temporal patterns in six Asian and Oceanic countries. Chen B; Zhao Y; Jin Z; He D; Li H BMC Infect Dis; 2023 Jan; 23(1):25. PubMed ID: 36639649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]